PathCision Medicine, Inc. — Form D/A
PathCision Medicine, Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2026-02-05. The offering totals $3.0M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-02-05
- Form: D/A
- Accession: 0001959064-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.7M
- Remaining: $1.3M
- Investors: 8
- Date of first sale: 2022-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505665
Issuer
- Name: PathCision Medicine, Inc.
- CIK: 0001959064
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472
- Phone: 6172493225
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Yang Lee | Related Person | Watertown, MA |
| Hui-Hsuan Wang | Related Person | Watertown, MA |
| Yang Lee | Director | Watertown, MA |
| Yang Lee | Executive Officer | Watertown, MA |
| Hui-Hsuan Wang | Director | Watertown, MA |
| Hui-Hsuan Wang | Executive Officer | Watertown, MA |
Other filings by this issuer (2)
More